GLAUKOS Corp (GKOS) 8-K Current Report: March 2, 2026
Filed: March 2, 2026
Health Care
Surgical & Medical Instruments & ApparatusGLAUKOS Corp (GKOS) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 7.01: Regulation FD Disclosure
GLAUKOS Corp 8-K Mar 2, 2026 Event Analysis
Item 7.01 · Regulation FD Disclosure
- • Glaukos releasing updated investor presentation materials to be used in ongoing investor/stakeholder meetings
- • Presentation posted to investor relations site at investors.glaukos.com — signals active investor engagement period, potentially ahead of a conference or roadshow
- • Full substance of disclosed information contained in Exhibit 99.1 — review that filing for financial targets, pipeline updates, or strategic messaging
Get deeper insights on GLAUKOS Corp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.